These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36733994)

  • 1. Separation and identification of degradation impurities of esomeprazole sodium.
    Xiao C; Yuan Y; Li J; Han Y; Shi J; Zeng W; Zu X; Jin H; Jiang R; Ni S
    Biomed Chromatogr; 2023 May; 37(5):e5593. PubMed ID: 36733994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of degradation products in stressed tablets of Rabeprazole sodium by HPLC-hyphenated techniques.
    Vasu Dev R; Sai Uday Kiran G; Venkata Subbaiah B; Suresh Babu B; Moses Babu J; Dubey PK; Vyas K
    Magn Reson Chem; 2009 May; 47(5):443-8. PubMed ID: 19173350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Separation and identification of impurities from intermediates of istradefylline].
    Wang Y; Lü X; Xu H; Meng Z; Li J; Xu Z; Xue M
    Se Pu; 2021 Apr; 39(4):430-436. PubMed ID: 34227764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, characterization and synthesis of impurities of zafirlukast.
    Goverdhan G; Reddy AR; Srinivas K; Himabindu V; Reddy GM
    J Pharm Biomed Anal; 2009 May; 49(4):895-900. PubMed ID: 19231127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of potential impurities of rabeprazole sodium.
    Reddy GM; Bhaskar BV; Reddy PP; Sudhakar P; Babu JM; Vyas K; Reddy PR; Mukkanti K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1262-9. PubMed ID: 17134865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of unknown impurities in Coenzyme Q
    Deng Y; Chen X; Wang L; Peng X; Lin M
    J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, identification and structure elucidation of two novel process-related impurities of retigabine.
    Zhang D; Song X; Su J
    J Pharm Biomed Anal; 2014 Oct; 99():22-7. PubMed ID: 25047423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, identification and characterization of novel process-related impurities in flupirtine maleate.
    Zhang D; Song X; Su J
    J Pharm Biomed Anal; 2014 Mar; 90():27-34. PubMed ID: 24333703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and identification of four major impurities in capreomycin sulfate.
    Liu G; Luan B; Liang G; Xing L; Huang L; Wang C; Xu Y
    J Chromatogr A; 2018 Oct; 1571():155-164. PubMed ID: 30115387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
    Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B
    J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC separation, synthesis, isolation and characterization of process related and degradation impurities in larotaxel including method development and validation.
    Yao K; Wang H; Xie X; Li J; You R; Li Y; Zhang H
    J Pharm Biomed Anal; 2023 Sep; 233():115435. PubMed ID: 37196590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
    Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
    Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and genotoxicity evaluation of potential impurities in rabeprazole sodium using
    Du Y; Wu Y; Liu Y; Meng C; Tan L; Cai T; Wang Y; Lu Y
    Drug Chem Toxicol; 2022 Sep; 45(5):2116-2122. PubMed ID: 33829945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impurity profile study of zaleplon.
    Bharathi Ch; Prabahar KJ; Prasad ChS; Kumar MS; Magesh S; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 May; 44(1):101-9. PubMed ID: 17367980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, synthesis and characterization of impurities in celecoxib, a COX-2 inhibitor.
    Satyanarayana U; Rao DS; Kumar YR; Babu JM; Kumar PR; Reddy JT
    J Pharm Biomed Anal; 2004 Jun; 35(4):951-7. PubMed ID: 15193741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural identification and characterization of potential impurities of pantoprazole sodium.
    Reddy GM; Bhaskar BV; Reddy PP; Ashok S; Sudhakar P; Babu JM; Vyas K; Mukkanti K
    J Pharm Biomed Anal; 2007 Oct; 45(2):201-10. PubMed ID: 17629653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.